Federal regulators Friday authorized the antiviral drug remdesivir for covid-19 outpatients at high risk of being hospitalized, providing a new treatment option for doctors struggling with shortages of effective drugs to counter the coronavirus.
The number of COVID-19 hospitalizations have hit a record high, but there are signs in the country and around the world that the coronavirus could be slowing.